COVID-19 rapid guideline: managing the long-term effects of COVID-19

Evidence reviews - November 2021

The following documents contain the evidence that was used to develop the November 2021 recommendations:

• Risk factors (update)
• Case definition
• Signs and symptoms (update)
• Children and young people
• Impact of vaccines (update) (updated August 2022)

The following documents contain the qualitative reviews conducted by SIGN:

• Case definition (SIGN)
• Barriers to and facilitators of, timely referral to specialist care (SIGN)

Evidence reviews - December 2020

The following documents contain the evidence that was used to develop the December 2020 recommendations:

• Risk factors
• Prevalence
• Investigations
• Interventions
• Monitoring and referral
• Service organisation

The following document contains the qualitative review conducted by SIGN:

• The views and experiences of patients, their families and carers (SIGN)

Other supporting evidence

• Supporting document 1: Excluded studies report for evidence reviews A to F
• Supporting document 2: Expert testimony for rehabilitation
• Methods: Chapter 1
• Methods: Chapter 2